Trial intelligence / Profile preview

POLAR: Sirolimus and Laser for Port Wine Stains

NCT02214706Terminated

Sponsor
Erasmus MC
Start
Jul 2014
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of sirolimus in port-wine stain (4 arms), sponsored by Erasmus MC. Primary endpoint: Percentage clearance assessed colorimetrically at 10 weeks. Started Jul 2014; status: terminated.

02

Drugs

sirolimus
03

Conditions

port-wine stain

Beyond the preview

Go deeper on NCT02214706.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02214706.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call